Valuation : Healius Limited

Market Cap 312M 224M 193M 183M 165M 310M 21.36B 2.17B 833M 10.88B 839M 821M 34.34B P/E 2026
-0.68x
P/E 2027 * -29.9x
Enterprise Value 1.22B 873M 753M 713M 645M 1.21B 83.45B 8.47B 3.26B 42.5B 3.28B 3.21B 134B EV / Sales 2026
0.88x
EV / Sales 2027 * 0.88x
Free-Float
77.72%
Yield 2026 *
-
Yield 2027 * 2.89%
1 week-5.49%
Current month+1.18%
1 month+2.38%
3 months+19.44%
6 months-27.73%
Current year-52.49%
1 week 0.42
Extreme 0.425
0.48
1 month 0.39
Extreme 0.39
0.51
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
2.54
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26 Expiration

Director

-22,977 0.0032%
8/27/26 Exercice

Director

22,977 0.0032%
8/18/26 Expiration

Chief Executive Officer

-305,462 0.0421%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.49% - - 224M
Average 0.00%
Weighted average by Cap. 0.00%

Financials

2026 2027 *
Net sales 1.38B 987M 851M 806M 729M 1.37B 94.29B 9.57B 3.68B 48.02B 3.7B 3.62B 152B 1.41B 1.01B 873M 827M 748M 1.4B 96.75B 9.81B 3.78B 49.27B 3.8B 3.72B 156B
Net income -27.45M -19.65M -16.95M -16.05M -14.52M -27.25M -1.88B -190M -73.26M -956M -73.77M -72.17M -3.02B -10.8M -7.73M -6.67M -6.32M -5.71M -10.72M -739M -74.96M -28.83M -376M -29.03M -28.4M -1.19B
Net Debt 908M 650M 561M 531M 480M 901M 62.09B 6.3B 2.42B 31.62B 2.44B 2.39B 99.82B 934M 668M 576M 546M 494M 927M 63.86B 6.48B 2.49B 32.52B 2.51B 2.45B 103B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
6,000
Date Price Change Volume
26-09-11 A$0.4300 0.00% 3,722,045
26-09-10 A$0.4300 -2.27% 4,434,799
26-09-09 A$0.4400 -5.38% 1,587,036
26-09-08 A$0.4650 +1.09% 3,353,640
26-09-07 A$0.4600 +1.10% 2,744,991
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.4300AUD
Average target price
0.5474AUD
Spread / Average Target
+27.30%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!